mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
AS601245 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.1 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
pac-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
ML050 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
Dasatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.1 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
-0.045 |
0.1 |